Lee Daniel Flynn Net Worth & Insider Trades
Lee Daniel Flynn - Chief Scientific Officer, Deciphera Pharmaceuticals, Inc
What is Lee Daniel Flynn's Net Worth?
The current estimated net worth of Deciphera Pharmaceuticals, Inc's Chief Scientific Officer, Lee Daniel Flynn, is estimated to be about $30.32M . Lee Daniel Flynn owns about 106,646 units of Deciphera Pharmaceuticals, Inc common stock. In the last 5 years at Deciphera Pharmaceuticals, Inc, Lee Daniel Flynn has sold an estimated value of $29M worth.
What is Lee Daniel Flynn's Past Insider Trading?
Lee Daniel Flynn's largest purchase order was 152,927 units , worth over $289.03K on December 11, 2019. Lee Daniel Flynn's largest sale order was 152,927 units , worth over $8.41M on December 11, 2019. In total, Lee Daniel Flynn has made about 23 transactions over 5 years of their time at Deciphera Pharmaceuticals, Inc. Lee Daniel Flynn usually trades in February, with the busiest year in 2019. The most recent transaction was a sale order of 1,655 units , worth over $23.83K on June 21, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lee Daniel Flynn
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Lee Daniel Flynn's' Mailing Address?
- Mailing address is C/o Deciphera Pharmaceuticals, Llc 500 Totten Pond Road Waltham MA 02451 MA
Deciphera Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
Steven L. Hoerter | 2020 | $650,000 | - | - | $6,597,306 | $536,250 | $11,388 | $7,794,944 |
Steven L. Hoerter | 2019 | $449,886 | - | $1,320,800 | $6,776,000 | $478,500 | - | $9,025,186 |
Thomas P. Kelly | 2020 | $447,200 | - | $386,285 | $1,546,335 | $272,278 | $7,386 | $2,659,484 |
Thomas P. Kelly | 2019 | $430,000 | - | - | $1,308,788 | $336,690 | $11,200 | $2,086,678 |
Thomas P. Kelly | 2018 | $370,000 | - | - | $1,755,252 | $175,000 | $11,000 | $2,311,252 |
Matthew L. Sherman, M.D. | 2020 | $504,986 | - | $96,571 | $385,576 | $307,461 | $5,962 | $1,300,556 |
Matthew L. Sherman, M.D. | 2019 | $125,000 | $150,000 | $1,205,050 | $3,458,715 | $84,593 | $115,164 | $5,138,522 |
Daniel L. Flynn, Ph.D. | 2020 | $442,000 | - | $386,285 | $1,546,335 | $269,112 | $11,400 | $2,655,132 |
Daniel C. Martin | 2020 | $436,800 | - | $386,285 | $1,546,335 | $247,141 | $23,882 | $2,640,443 |
Daniel C. Martin | 2019 | $420,000 | - | - | $907,426 | $253,344 | $505,549 | $2,086,319 |
Daniel C. Martin | 2018 | $117,875 | $100,000 | $722,000 | $2,189,097 | $45,000 | $702 | $3,174,674 |
Stephen B. Ruddy, Ph.D. | 2020 | $383,400 | - | $386,285 | $1,546,335 | $216,928 | $1,212 | $2,534,160 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415121000007/dcph-2021xproxystatement.htm
What are Deciphera Pharmaceuticals, Inc's Past Insider Trades?
Deciphera Pharmaceuticals, Inc's most recent insider trade came on June 21, 2023 by Jama Pitman who sold 1,238 units worth $17.83K . In the last 6 years, insiders at Deciphera Pharmaceuticals, Inc have sold an estimated value of $103.47M and bought an estimated value of $63.62M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Douglas Michael Taylor, Director, Patrick Thomas Kelly, Chief Financial Officer, and Lee Daniel Flynn, Chief Scientific Officer .
Deciphera Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |